Bayesian Capital Management’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-11,900
Closed -$109K 737
2019
Q2
$109K Sell
11,900
-13,196
-53% -$138K 0.02% 459
2019
Q1
$278K Buy
+25,096
New +$175K 0.05% 402
2017
Q2
Sell
-8,538
Closed -$262K 636
2017
Q1
$262K Buy
+8,538
New +$241K 0.12% 284

Other funds holding DBD

Bayesian Capital Management's DBD Position: Q3 2019 in Review

Bayesian Capital Management sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2019, closing a stake of 11,900 shares — an estimated $109K sold.

Bayesian Capital Management first reported a position in DBD in Q1 2017 and held it in 3 quarters. The position peaked at $278K in Q1 2019. 206 funds tracked by Wall St. Rank hold DBD as of Q3 2019.

  • Bayesian Capital Management reported no remaining Diebold Nixdorf Incorporated position as of Q3 2019 after selling out during the quarter.
  • Bayesian Capital Management sold 11,900 Diebold Nixdorf Incorporated shares in Q3 2019, an estimated $109K.
  • Bayesian Capital Management first reported a position in Diebold Nixdorf Incorporated in Q1 2017 and held it in 3 quarters.
  • Bayesian Capital Management's Diebold Nixdorf Incorporated position peaked at $278K in Q1 2019.
  • 206 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2019.

Based on Bayesian Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.